Contraception Requirements in Clinical Trials

This Viewpoint proposes a risk-based approach toward contraception use in clinical trials of investigational products, which could improve access and inclusivit

Related Keywords

Jeanne Marrazzo ,Jennifere Balkus ,Centers For Disease ,Human Development ,Human Services ,National Institute Of Allergy ,National Institutes Of Health ,Us Centers For Disease ,National Survey On Family Growth ,Prevention Foundation ,Division Of Infectious Diseases ,University Of Alabama At Birmingham ,American College Of Obstetricians ,University Of Washington School Public Health ,Us Department Of Health ,Department Of Medicine ,National Institute ,Infectious Diseases ,American College ,National Survey ,Family Growth ,Disease Control ,National Institutes ,Health Task Force ,Research Specific ,Pregnant Women ,Lactating Women ,Washington School ,Public Health ,Interest Disclosures ,Eunice Kennedy Shriver National Institute ,Child Health ,Transmitted Infections Clinical Trials Group ,Sexually Transmitted Infection Research ,Cisgender Women ,Reproductive Age ,